RPL32P28

Across TCGA pan-cancer cohorts, RPL32P28 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL32P28 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL32P28 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL32P28 expression acts as an unfavorable survival marker, although some lineages such as READ and STAD show a favorable association.

KIRC, LUAD, and UCEC are the cancer types where RPL32P28 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.512	0.687	<.001	140	view →
LUAD	OS	Tertile	All	0.285	0.679	.003	39	view →
UCEC	DFS	Tertile	All	0.749	0.860	.002	30	view →
PCPG	OS	Tertile	All	0.863	0.979	.014	30	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
THYM	DFS	Tertile	II,III,IV	0.413	0.825	.014	15	view →
READ	OS	Tertile	IV	0.995	0.572	.021	12	view →
BLCA	DFS	Tertile	IV	0.236	0.508	.040	9	view →
THCA	DFS	Tertile	III,IV	0.528	0.783	.027	9	view →
STAD	OS	Quartile	IV	0.682	0.251	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPL32P28–KIRC (OS)

Open the KIRC breakdown →